Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

not_yet_recruiting125%
unknown250%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruiting

Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)

NCT06547138
unknownnot_applicable

Prophylactic Mesh in Cytoreductive Surgery

NCT03953365
unknownnot_applicable

Prophylactic Mesh to Reduce The Incidence of Ventral Hernia

NCT01788826
completedphase_4

Prevention of Parastomal Hernia With a Mesh

NCT00509054

Clinical Trials (4)

Showing 4 of 4 trials
NCT06547138

Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)

Not Yet Recruiting
NCT03953365Not Applicable

Prophylactic Mesh in Cytoreductive Surgery

Unknown
NCT01788826Not Applicable

Prophylactic Mesh to Reduce The Incidence of Ventral Hernia

Unknown
NCT00509054Phase 4

Prevention of Parastomal Hernia With a Mesh

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4